Topical brinzolamide (Azopt) versus placebo in the treatment of infantile nystagmus syndrome (INS)

摘要

Purpose To test the hypothesis that the topical carbonic anhydrase inhibitor brinzolamide (Azopt) has beneficial effects versus placebo on measures of nystagmus and visual acuity in adult subjects with infantile nystagmus syndrome (INS).